Clin2
NCT07499713Possibly a fitEnrolling by invitation

Blood proteins and nail blood vessels in alopecia areata

Alopecia AreataAlopecia Areata(AA)Alopecia Areata (AA)

Part of Skin clinical trials.

This study looks at whether certain proteins in your blood (VEGF-A and VCAM-1) are linked to changes in the tiny blood vessels at the base of your fingernails in people with alopecia areata. It may help doctors understand more about the condition and how it affects the body.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
90 people
Ages
18 years to 60 years
Study type
Observational

Who can take part

  • You are between 18 and 60 years old.
  • You have been diagnosed with alopecia areata by a dermatologist.
  • You do not have diabetes, autoimmune diseases, or other chronic inflammatory or vascular conditions.
  • You are not pregnant or breastfeeding.
  • You do not smoke or drink heavily.
  • You have not had a manicure in the last 3 weeks and have no other nail disease.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07733063Recruiting
Blood markers for ferroptosis in Alopecia Areata

This study looks at certain blood markers (GPX4 and MDA) related to a process called ferroptosis in people with Alopecia Areata. The goal is to better understand this condition and possibly find new treatment targets.

Istanbul, Cerrahpasa Mahallesi
NCT06327581Recruiting
Microneedling with creams for patchy hair loss

This trial tests if microneedling with either lactic acid, vitamin D3, or a steroid cream helps regrow hair in people with patchy alopecia areata (small bald spots).

Zagazig
NCT07749716Recruiting· Phase 2
Oral tablet for severe hair loss

This study tests an experimental oral tablet for severe alopecia areata, a condition that causes patches of hair to fall out. The goal is to see if it can help regrow hair safely. You may be able to join if you have this type of hair loss and meet the health requirements.

Beijing, Beijing Municipality
NCT07762443Not yet recruiting· Phase 1
Study drug for severe hair loss in teens

This trial tests an experimental tablet for teenagers with severe alopecia areata, a condition causing patchy hair loss. The treatment may help regrow hair with clearer information about safety and effectiveness.

Beijing, Beijing Municipality
NCT03976622Enrolling by invitation
Inflammation study in vitiligo and other skin conditions

This study looks at inflammation in people with vitiligo, psoriasis, atopic dermatitis, or alopecia areata. It aims to understand how these conditions compare, which may lead to better treatments.

Bordeaux, Bordeaux
NCT07705217Not yet recruiting
Gut bacteria transplant for alopecia areata

This study tests whether changing the bacteria in your gut (using a fecal transplant given as capsules or through a colonoscopy) can help treat alopecia areata, a condition that causes hair loss. It looks at how gut and skin bacteria are linked to your hair loss.

Opatija

Hear when a new Alopecia Areata trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.